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1. Introduction
  Intractable epilepsy[1-4] (IE) is a disease that does not involve 
organic diseases in the central nervous system; healing is delayed 
after more than two years of formal antiepileptic treatment that a 
variety of anti-epileptic drugs are combined. The disease still cannot 
be controlled, even by achieving an effective blood concentration. 
Patients cannot live a normal life[5-9]. There may still be possible 
varieties of pathogenesis, such as the multi-drug resistance 
mechanism and the neural network restructuring mechanism[10-
14]. According to the research of Du et al, mossy fiber sprouting is 
a common pathological basis for the pathogenesis of epilepsy with 
the basis of synaptic plasticity[15]. Mossy fiber sprouting is the basis 
of seizures, which may also be the result of repeated long-term 
epileptic seizures. Therefore, epilepsy can be treated fundamentally 
by clearly investigating the basic molecular biology of the mossy 
fiber sprouting only. Studies by Cohen[16] and Bassell[17] show that 
certain types of mammalian MicroRNA are associated with synaptic 
plasticity. MicroRNA-134 in rat hippocampus inhibits the formation 
Objective: To To investigate the changes of MicroRNA-134, CREB and p-CREB expression in 
epileptic rat brains in order to elucidate the molecular mechanisms of epilepsy, providing new 
ideas for clinical treatment. Methods: Sixty-four Spraque-Dawley (SD) rats were divided into 
groups randomly, including control group, six hours after seizure group, 24-hour group, three-
day group, one-week group, two-week group, four-week group, and eight-week group. All 
groups were placed under a pilocarpine-induced epilepsy model except the control group, and 
all rats were decapitated in different points of time. Brain specimens were taken for quantitative 
PCR experiments, immunohistochemistry and Western blot experiments. The results of 
the epilepsy model groups and the control group were compared. Results: There were no 
significant differences between the six hours after seizure group, the 24-hour group and the 
control group about the MicroRNA-134 levels. MicroRNA-134 in the hippocampus tissue of 
the three-day group significantly reduced compared with the control group; same result was 
observed with the one-week, two-week, four-week and eight-week groups. The CREB and 
p-CREB levels in the three-day group’s rat hippocampus significantly increased compared 
with the control group; and the high levels of CREB and p-CREB were constantly maintained 
in the one-week, two-week, four-week and eight-week groups. Conclusions: The MicroRNA-
134 level of the epileptic rat hippocampus is significantly lower than normal after three days, 
and continues to maintain a low level; while CREB and p-CREB levels are rsignificantly 
increased after three days, and continue to remain at a high level. MicroRNA-134 plays a role 
in inhibiting synaptic plasticity by inhibiting CREB and p-CREB expressions.
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of synapses that exists only in brain tissue[18]. Studies by Gao[19] 
found that MicroRNA-134 regulates synaptic plasticity by regulating 
the phosphorylated cAMP-response element binding protein (CREB) 
and CREB. Various findings relevant to MicroRNA-134, CREB 
and phosphorylated CREB variations in rat hippocampus need to 
undergo further studies. MicroRNA-134, CREB and phosphorylated 
CREB variations in rat hippocampus may provide new insights 
for treating epilepsy by molecular targeted therapy, which could 
also be used as a foundation for further studying the mechanisms 
of epilepsy. Therefore, in this study, changes of MicroRNA-134, 
CREB, and phosphorylated CREB in the hippocampus of epileptic 
rats needs further analysis, as reported below.
2. Materials and methods
2.1. Experimental animals
  Sixty-four clean Spraque-Dawley (SD) male rats were selected 
for the study; body weight was approximately 200g; and the rats 
were reared on free diet in the laboratory by animal laboratory 
professionals. 
2.2. Method
2.2.1. Animal groups  
  Eight rats were randomly selected as the control group and the 
remaining rats were introduced to an epilepsy model. The epilepsy 
model rats were randomly divided into 7 groups; six hours after 
seizure group, 24-hour group, three-day group, one-week group, 
two-week group, four-week group and eight-week group; each group 
have at least five animals.
2.2.2. Establish an epileptic rat model 
  Lithium chloride was intraperitoneally-administered to the rats, 
based on the 127 mg/kg dosage. After eighteen hours, the rats 
were treated with a 40 mg/kg dose of pilocarpine, administered 
intraperitoneally. Twenty minutes before administering pilocarpine, 
the rats were intraperitoneally-administered with 1 mg/kg of 
atropine in order to prevent serious cholinergic reactions. Saline 
was administered to the control group with the same dosage. 
When seizures reached stage 4 or 5, the rats were given 10mg/kg 
of diazepam to terminate the seizures after one hour. According to 
Racine Stages, “0” no abnormal reactions; “1” blinking, rhythmic 
chewing-clonic movements and other facial expression appear; 
“2” paroxysmal nods appear; “3” bilateral forelimb clonus occurs; 
“4” hind limb standing; and “5” all symptoms above with falling 
movements occurs.
2.2.3. Preparation and production of tissue specimen for 
biopsy 
  Each group was anesthetized by 3.5% chloral hydrate; 
intraperitoneally administering a 0.1 mL/kg dosage after 6 hours, 24 
hours, three days, one week, two weeks, four weeks and eight weeks, 
respectively. The hippocampus was peeled and placed into EP tubes 
without RNA enzymes; and stored in a refrigerator at -80 曟 to be 
used as materials for quantitative PCR and western blot experiments.
After anesthetization, the rats were perfusion-fixed with 4% 
paraformaldehyde (250 mL); the hippocampus was removed, 
separated from brain, and fixed with a 4% paraformaldehyde 
for approximately 2 hours. The specimens were embedded in 
paraffin and cut into slices (5 毺m) to be used as materials of 
immunohistochemistry.
2.2.4. Quantitative PCR experiments
  Approximately 50-100 mg of hippocampus tissue was placed in 
the tube and 1 mL of RNAiso Plus was added with a dropper. The 
specimen was homogenized on ice until the polishing fluid became 
clear, and moved to a tube without RNase. 1.2 mL of chloroform 
was added, and the centrifuge tube was stamped for 30 seconds 
after the turbulence. The specimen was placed on ice for 5 minutes, 
and placed under a centrifuge speed of 12 000 r/minute for fifteen 
minutes. The centrifugal supernatant was transferred to a fresh tube 
without RNase, added 0.5 mL of chloroform, and placed on ice 
for ten minutes after turbulence; the specimen was centrifuged for 
fifteen minutes with the same speed. Afterwards, the supernatant was 
discarded, added with 75% ethanol, and was centrifuged for seven 
minutes with a speed of 7 500 r/minute. The alcohol was discarded; 
and after drying the tube, RNase-free water was added to dissolve 
the RNA pellet. 
  After determining the RNA concentration, the RNA was retained 
at 1.8-2.0 during 260 nm/280 nm, as a material for cDNA reverse 
Table 1 
RNA reverse transcription system and PCR fluorescence quantitative reaction system.  
RNA reverse transcription system PCR fluorescence quantitative reaction system 
5×PrimeScript buffer (for Real time) 2 毺L SYBR Premix Ex Taq
TM
栻(2暳) 5 毺L
Specific primer (2 毺M) 0.5 毺L PCR Forward primer (10 毺M) 0.5 毺L
Total RNA 2 毺g PCR Reverse primer (10 毺M) 0.5 毺L
RNase free dH2O up to the total volume 10 毺L cDNA template 1 毺L
Total 10 毺L RNase free dH2O 3 毺L
Total 10 毺L
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transcription; reverse transcription procedures were all done on ice. 
During the experiment, the centrifuge tube and Pipette tips were all 
RNase free. After reverse transcription, the specimen was cooled on 
ice. Spare cDNA results were stored at -20 曟.
  Fluorescence quantitative PCR; ① each cDNA tissue sample was 
pipetted three times; ② Fluorescence quantitative PCR reaction 
steps (95 曟 for 30 s, 95 曟 for 5 s, 60 曟 for 20 s, 72 曟 for 10 s, 35 
cycles ); ③ After PCR amplification reactions were completed, the 
temperature was gradually increased from 55 曟 to 95 曟 at a speed 
0.5 曟 every 5 seconds to draw a melting curve. The RNA reverse 
transcription and PCR fluorescence quantitative reaction systems are 
shown in Table 1.
2.2.5. Western blot experiments
  One 毺L of phosphatase inhibitors (sodium pyrophosphate), 1 
mL Lysis buffer and 5 毺L PMSF were added in a uniform shock-
resistant centrifuge tube. The contents were made into protein 
extracts and placed on ice. As for the 100 mg rat hippocampus, 
600 毺L protein extracts were added; tissue homogenates were 
homogenized with a glass homogenizer until it become clear; and 
was transferred into a new centrifuge tube and centrifuged at 10 000 
r/min for five minutes. The supernatant was dispensed into two 
centrifuge tubes. After determining the protein concentration in the 
supernatant, 50 毺g of protein and a volume of 5伊SDS solution were 
added in a uniform shock-resistant centrifuge tube. The tube was 
sealed, submersed in boiling water for ten minutes, and stored in the 
refrigerator at 4 曟.
  Protein concentration assay solution and standard protein solution 
were prepared according to the manual of BCA protein kit. Three 
毺L of brain homogenate and 57 毺L of buffer were thoroughly 
mixed, which were added to 3 wells of the 96-well plates. Each 
well was filled up to 20 毺L; the protein concentration assay 
solution was added into each well, placed in the incubator for 
half an hour, and the A562 wavelength was measured and plotted. 
The protein concentration’s standard curve was drawn, and the 
protein concentration was calculated based on the standard protein 
concentration curve. According to the molecular weight of the 
protein, a 10% separating gel was used; which was solidified to 5% 
with a stacking gel comb. After the stacking gel was solidified, the 
comb was pulled out, and a liquid sample was poured to begin the 
electrophoresis.
  A 1伊SDS buffer was initially poured for electrophoresis, the marker 
protein and the hippocampal protein of each group were added; 毬
-mercaptoethanol was added afterwards, and boiled with an initial 
voltage of 60 volts. After the gel sample started to separate, the 
voltage level was raised to 120 volts, and the current voltage was 
maintained until the bromine finland indicator gel electrophoresis 
reached the next downstream. A stack was placed together into an 
electrophoresis tank in the following order: PVDF membrane, gel 
electrophoresis, a three-sheet filter; and was fixed on ice with an 
electrical current of 250 mA for 60 minutes. The PVDF membrane 
was transferred to a 5% skimmed powder box for an hour with 
a temperature of 37 曟 combined with tissues from non-specific 
antibody binding sites. The CREB, p-CREB and 毬-actin antibody 
were refrigerated at 4 曟 for spare, after diluting 100, 500, and 1 000 
folds. According to the displayed electrophoretic bands, the PVDF 
CREB, p-CREB and 毬-actin proteins reside were cut and immersed 
overnight into its corresponding primary diluted antibody liquid, 
at a temperature of 4 曟. The PVDF strips were washed four times 
with Tris-Buffered Saline Tween-20 (TBST). The Goat anti-rabbit 
secondary antibody was diluted 4 000 times with TBST. The PDVF 
membranes were incubated for an hour in the secondary diluted 
antibodies at 37 曟; and were immersed in TBST to be shake-
washed for four times, at about ten minutes each time. Luminescent-
liquid-one and luminescent-liquid-two were mixed at a 1:1 ratio, and 
was added to the membrane. Gel strip images were obtained when 
light was emitted from the UV gel imager. Quantity one was the 
image analysis software used to calculate the optical density of each 
band in order to obtain the expression of the tissue’s protein.
2.2.6. Immunohistochemistry
  Tissue slices were immersed in a xylene solution 栺 and 栻, and 
incubated for 20 minutes at 60 曟. These were then immersed in a 
100%, 95%, 80%, and 70% alcohol solution for five minutes, one at 
a time; and tissue slices were soaked in a PBS solution for 5 minutes.
  The slices were immersed in a citric acid solution and placed in a 
microwave for antigen retrieval; the temperature was raised to the 
maximum level for 3 or 4 minutes until the solution boiled; then, 
the temperature was adjusted and maintained at a low level for 20 
minutes. The slices were added in the PBS solution for three minutes 
after cool down to room temperature for cleaning, which was washed 
for a total of three times. 3% hydrogen peroxide solution was added 
in the slice, and was kept at room temperature for 15 minutes; then 
the slice was washed three times with a PBS solution, three minutes 
per time. 
  Dropwise Goat serum was added and incubated for half an hour at 
37 曟. Diluted CREB and p-CREB antibody solutions were added. 
The slices were incubated at 37 曟 for two hours. After incubation, 
the slices were washed three times with a PBS solution, five minutes 
each time. Secondary antibody was added to the slice, incubated for 
20 minutes at 37 曟, and was washed three times again with a PBS 
solution, five minutes each time. SABC solution was added in the 
slices, incubated for 20 minutes, and washed three times with a PBS 
solution at 37 曟, five minutes each time. 
  A drop of color-liquid from the DAB chromogenic kit and 1ml 
double distilled water were mixed without light; the color-liquid was 
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added on the slices. When the color darkened from the background, 
the reaction was stopped by adding water. The slices were washed 
three times with tap water, placed in a hematoxylin stain for four 
minutes, washed with tap water three times again, and dipped in 
a 1% hydrochloric acid for one second for differentiation. After 
washing three times with tap water, the slices were soaked in a 
lithium saturated solution for twenty seconds; then, the slices were 
observed under the microscope after staining the nuclei of neurons 
examining under the microscope, after the slices were dried.
2.3. Experimental equipment 
  Ultra-pure water system (MILLI-Q)(Millipore USA); Optical 
microscope (BX 51) (Olympus, Japan); CFX96 Real time PCR 
instrument, electrophoresis and electroporation instrument(Bio-
Rad America); gel/luminescent image analysis system (ChemiDoc 
XRS); Visible / UV gel scanning analysis system UVP (Britain); 
slicers (RM2135)(Leica German); thermostatic water bath(Jiangsu 
instrument).
2.4. Reagents
  Total protein extraction kit (Nanjing KGI); BCA Protein Assay 
Kit (Enhanced)(Haibi sky); 毬-actin, P-CREB polyclonal antibody 
(Santa America);paraformaldehyde PVDF membrane (Millipore 
USA);pilocarpine, lithium chloride, glycine, Tris base (Sigma 
USA);Tween-20, Triton-X100, SDS, Protein Marker (Fermentas); 
SABC kit, DAB chromogenic kit (Beijing Zhongshan Golden 
Bridge); IgG, CREB polyclonal antibody (Cell signaling technology 
USA); 0.01 M PBS buffer, polylysine on SDS-PAGE sample buffer 
(5暳) (Wuhan Boster China); kim milk, citrate buffer, and miR-134-
specific reverse transcription and PCR primers (Guangzhou RiboBio 
Ltd.); DEPC (Invitrogen America); SYBR Premix Ex Taq™ 栻,
RNAiso Plus (Takara China); PrimeScript RT reagent Kit (Takara 
China).
2.5. Statistical analysis
  IBM SPSS19.0 software was applied for statistical analysis. 
Normally distributed data were expressed in, and the measured data 
was compared using ANOVA analysis. Independent t-test sample 
was used for comparing the groups. P<0.05 represents statistical 
significance.
3. Result 
3.1. MicroRNA-134 expression in each group of rats
  After 10-15 cycles of PCR amplification, the MicroRNA-134 CT 
values of the six hours after seizure group and the 24-hour group 
had no significant difference compared with the control group, the 
result was not statistically significant (P>0.05). The MicroRNA-
134 expression levels of the three-day-group began to decrease, 
and MicroRNA-134 levels in the hippocampus of the three-day, 
one-week, two-week, four-week and eight-week groups decreased 
significantly, compared with the control group. The difference had 
statistical significance (P<0.05), as shown in Table 2. 
3.2. Immunohistochemistry
3.2.1. CREB expression of a rat model’s brain tissue
  CREB was expressed in all cells of brain CA3, CA1 neurons of the 
three-day group’s hippocampal nucleus; the CREB expression was 
significantly more than the control group, shown in Figure 1. 
 
Figure 1. CREB expression in rat hippocampal.
  
  Figure1-a, CREB expression figure in CA3, neurons of the 
control group’s nucleus, as shown by the arrow; Figure1-b, CREB 
expression in CA3, neurons in the three-day group’s nucleus, as 
shown by the arrow. Color bands in Figure1-b darkened, indicating 
that CREB neurons are significantly more than the control group. 
Figure1-c, CREB expression in CA1, neurons in the control group’s 
nucleus, as shown by the arrow; Figure1-d, CREB expression in 
CA1, neurons in the three-day group’s nucleus, as shown by the 
Table 2 
Comparison of MicroRNA-134 values in the rat hippocampus of each group.
Groups Control  6-hour 24-hour 3-day 1-week 2-week 4-week 8-week
MicroRNA-134 0.028依0.013 0.029依0.014 0.028依0.014 0.014依0.009 0.011依0.007 0.009依0.006 0.010依0.005 0.012依0.004
t value 2.463 4.382 6.349 10.342 9.054 11.342 9.563
P value 0.213 0.117 0.031 0.000 0.000 0.000 0.000
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arrow; color bands in figure-d darkened, indicating that CREB 
neurons are significantly more than the control group.
3.2.2. p-CREB expression of the rat model’s brain tissue 
  In the CA3, CA1 region of the hippocampal, the p-CREB 
expression levels of the three-day group were significantly more than 
the control group (Figure 2). 
Figure 2. p-CREB expression of the rats hippocampal.
  Figure-1a, p-CREB expression in CA3, neurons in the control 
group’s nucleus, as shown by the arrow; and Figure1-b, p-CREB 
expression in CA3, neurons in the three-day group’s nucleus, as 
shown by the arrow; color bands in Figure1-b are darker, indicating 
that p-CREB neurons are significantly more than the control group. 
Figure1-c, p-CREB expression in CA1, neurons in the control 
group’s nucleus, as shown by the arrow; and Figure1-d, p-CREB 
expression in CA1, neurons in the three-day group’s nucleus, as 
shown by the arrow; color bands of figure-d are darker, indicating 
that p-CREB neurons are significantly more than the control group.
3.3. Western blot experiment
  The CREB expression of the six hours after seizure group and the 
24-hour group showed no significant difference compared with the 
control group, the result was not statistically significant (P>0.05). 
Three days after seizures, the expression of CREB began to increase; 
and the expression of the three-day, one-week, two-week, four-week 
and eight-week groups significantly increased compared with the 
control group, the results had statistical significance (P<0.05), shown 
in Table 3. The expression of p-CREB of the six hours after seizure 
group increased significantly compared with the control group. The 
expression levels continued to remain high for eight weeks -- the 
results were statistically significant (P<0.05), shown in Table 4. The 
PVDF membrane strips and the CREB levels of the three-day group 
were both more than the control group compared with 毬-actin; and 
p-CREB began to increase in the six hours after seizure group for 







Control    6 h     24 h     3 d       1 w      2 w       4 w      8 w
Figure 3. CREB and p-CREB levels of the rat’s hippocampus in Western blot 
experiments. 
  With 毬-actin as a reference and CREB in the normal control 
group, the six hour after seizure group and the 24-hour group had 
no obvious PVDF membrane strips. The PVDF membrane strips 
of three-day group was obvious for eight weeks. The p-CREB of 
the six hours after seizure group had significant number of PVDF 
membrane strips until the end of the experiment; indicating that the 
CREB and p-CREB expressions increased significantly.
4. Discussion
  This study aims to investigate the expression level changes of 
MicroRNA-134, CREB and phosphorylated CREB; in different time 
periods after seizures of the rat’s hippocampus; exploring variations 
of the hippocampus substances mentioned above; which may give 
us a better understanding of the pathogenesis of epilepsy. This 
Table 3 
Comparison of CREB expression levels in the hippocampus between the epilepsy groups and the control group. 
Groups control  6-hour 24-hour 3-day 1-week 2-week 4-week 8-week
CREB 0.207依0.039 0.224依0.042 0.217依0.041 0.438依0.115 0.429依0.203 0.387依0.094 0.417依0.173 0.397依0.078
t value 4.877 7.235 10.214 12.369 8.572 12.672 9.754
P value 0.452 0.257   0.000   0.000 0.014   0.000 0.026
Table 4 
Comparison of p-CREB expression levels in the hippocampus between the epilepsy groups and the control group 
Groups control  6-hour 24-hour 3-day 1-week 2-week 4-week 8-week
P-CREB 0.183依0.047 0.245依0.039 0.201依0.064 0.388依0.057 0.412依0.061 0.397依0.052 0.387依0.071 0.411依0.049
t value 4.877 11.903 9.563 13.426 7.547 9.421 12.432
P value 0.023   0.014 0.011   0.000 0.012 0.000   0.000
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study can also help us to learn more about the signaling pathway of 
MicroRNA-134, and its interaction with CREB and phosphorylated 
CREB. Grasping the significance of the pathogenesis of epilepsy 
may contribute to its further in-depth study, at a genetic-level. All of 
these may provide new ideas for the gene therapy of epilepsy. 
4.1. Pathogenesis of epilepsy
  There are a variety of concepts in the pathogenesis of epilepsy; 
but the most common pathological mechanism is the mossy fiber 
sprouting. Mossy fiber sprouting is based on synaptic plasticity. 
A rat’s newborn synaptic epileptic brain tissue is considered as a 
pathological basis, due to the abnormal discharge activities of the 
rat hippocampus. In normal circumstances, normal MicroRNA-
134 concentrations can effectively inhibit abnormal formations 
of synapses. Studies have shown that MicroRNA-134 affects the 
development of synapses, and that large amounts of MicroRNA-
134 can induce the dendritic spine volume to reduce significantly. 
Currently, the common causes of the pathogenesis of epilepsy[21-
23] include: MicroRNA-134, CREB and phosphorylated CREB 
variations; these are still in the experimental stage and are being 
researched in epileptic rats findings still needs to be further 
confirmed. Studies of Nakagawa[24], Lubin[25] and Eacker[26] have 
shown: the signal transduction pathway mediated by MicroRNA-
134 can express by inhibiting specific genes, and that the amount 
of CREB and phosphorylated CREB inhibits the development of 
synapses preventing mossy fiber sprouting.
4.2. Expression of CREB and p-CREB inhibited by 
MicroRNA-134 (mi-R134)
  The study showed that after the PCR amplification of the rat 
hippocampus, the MicroRNA-134 CT values of the six hours after 
seizure group and the 24-hour group had no significant difference 
compared with the control group. However, MicroRNA-134 
expression of the rat hippocampus of the three-day group was 
significantly lower than the control group; and in one, two, four, and 
eight weeks, MicroRNA-134 expression levels were still significantly 
lower than the control group. All these findings showed that, after 
the seizures, the epileptic content pertaining to the MicroRNA-134 
of rat hippocampus-reduced in 3 days, and continuously maintained 
a low level. These results are similar to Yang Xiaolan’s findings; 
which may also be related to the effects of pilocarpine-inhibiting the 
MicroRNA-134 expression and reducing the inhibition of synaptic 
plasticity related issues.
  Immunohistochemistry and Western blot experiments have shown 
that the CREB expression of rat hippocampus levels of the six 
hours after seizure group and the 24-hour group had no obvious 
differences compared with the control group; on the other hand, the 
levels of the three-day, one-week, two-week, four- week, and eight-
week groups significantly increased. The three-day group’s p-CREB 
was also significantly higher, and this level was maintained for 
eight weeks. Therefore, the CREB and p-CREB expressions both 
increased; which may be related to the stimulation of the mossy fiber 
sprouting. In addition, both levels had the same trend; suggesting 
that CREB stimulates mossy fiber sprouting through p-CREB. 
Due to this observation, CREB and p-CREB had opposite trends 
verifying that CREB can be regulated by p-CREB. When the amount 
of MicroRNA-134 decreased, the CREB and p-CREB expressions 
would increase. This promotes a new abnormal synaptic formation, 
which leads to high levels of mossy fiber sprouting - forming an 
abnormal nerve grid loop in the brain tissue. Seizures occur through 
constant abnormal high-frequency discharge; but regulating the 
correlation of these three substances needs to be further confirmed. 
This study also provides us with new ideas for epileptic gene therapy 
applications, and developing new drugs at the genetic level - making 
it eventually possible to treat or prevent seizures. 
4.3. Prospects
  Although this study found that the MicroRNA-134 expression of 
the three-day group decreased and maintained a low level for eight 
weeks, this case still does not provide a clear answer after eight 
weeks. In addition, 24 hours after the seizure, the 24-hour group 
did not show any significant difference in the MicroRNA-134 
levels, compared with the control group; but there were significant 
differences with the three-day group. Thus, these findings should 
still be refined, as well as a more precise timing including the 
findings on CREB and p-CREB. The detailed steps in regulating 
the MicroRNA-134, CREB and p-CREB levels are still not clear; 
which requires further experiments and new concepts exploring the 
signaling pathways. This also requires multi-disciplinary researchers 
to explore further and search for strong evidence that could be used 
as a basis for treating epilepsy.
  In a word, the cause of epilepsy is still complex and vivid; and until 
now, the study of its pathogenesis is still in the animal experimental 
stage. The diversity of its pathogenesis further increased, which 
made it more difficult for clinicians and researchers. The mechanism 
of epilepsy still needs to be confirmed through more extensive 
research.
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